We are live on
!
Find out more
I
IberiaBank Portfolio holdings
AUM
$849M
1-Year Est. Return
10.44%
This Fund
S&P 500
This Quarter
Est. Return
+4.37%
1 Year Est. Return
+10.44%
3 Year Est. Return
+39.56%
5 Year Est. Return
+72.86%
10 Year Est. Return
–
AUM
$227M
AUM Growth
+$15.1M
(+7.1%)
Cap. Flow
+$4.46M
Cap. Flow
% of AUM
1.96%
Top 10 Holdings %
Top 10 Hldgs %
23.29%
Holding
160
New
10
Increased
77
Reduced
48
Closed
18
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Principal Financial Group
PFG
|
+$2.7M |
| 2 |
Amgen
AMGN
|
+$2.67M |
| 3 |
Emerson Electric
EMR
|
+$2.56M |
| 4 |
Qualcomm
QCOM
|
+$2.02M |
| 5 |
Johnson Controls International
JCI
|
+$1.57M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$2.88M |
| 2 |
Kohl's
KSS
|
+$2.17M |
| 3 |
Kimberly-Clark
KMB
|
+$1.41M |
| 4 |
Cincinnati Financial
CINF
|
+$1.38M |
| 5 |
AT&T
T
|
+$1.22M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 15.08% |
| 2 | Consumer Staples | 13.53% |
| 3 | Healthcare | 13.31% |
| 4 | Technology | 13.2% |
| 5 | Industrials | 11.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
CGI
GIB
$15.1B
| – | – |
-5,975
| Closed | -$285K |
|
152
Gilead Sciences
GILD
$162B
| – | – |
-6,421
| Closed | -$590K |
|
|
153
Kohl's
KSS
$2.17B
| – | – |
-46,442
| Closed | -$2.17M |
|
154
VanEck Agribusiness ETF
MOO
$972M
| – | – |
-6,691
| Closed | -$312K |
|
155
Open Text
OTEX
$6.15B
| – | – |
-9,570
| Closed | -$248K |
|
156
Stanley Black & Decker
SWK
$14.3B
| – | – |
-2,049
| Closed | -$216K |
|
|
TGNA
157
DELISTED
TEGNA Inc
TGNA
| – | – |
-20,003
| Closed | -$300K |
|
158
Thermo Fisher Scientific
TMO
$213B
| – | – |
-2,721
| Closed | -$385K |
|
|
SGY
159
DELISTED
Stone Energy
SGY
| – | – |
-1,760
| Closed | -$79K |
|
|
GCI
160
DELISTED
Gannett Co., Inc
GCI
| – | – |
-10,733
| Closed | -$162K |
|
Similar funds
MC
FTI
AWM
ACC
IC
ACMV
NIT
BHG
IberiaBank's Q2 2016 Portfolio in Review
As of Q2 2016, IberiaBank held 160 positions worth $227M, up 7.1% from $212M the previous quarter. Its ten largest holdings account for 23% of the portfolio.
IberiaBank's Q2 2016 filing shows 10 new, 77 increased, 48 reduced and 18 closed positions. Its largest new stake was Principal Financial Group: 64,018 shares worth $2.63M. The largest sale was Bristol-Myers Squibb, an estimated $2.88M.
By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 13% a quarter earlier, followed by Consumer Staples and Healthcare.
- IberiaBank's largest Q2 2016 buy was Principal Financial Group: 64,018 shares worth $2.63M.
- IberiaBank added most to Amgen in Q2 2016, an estimated $2.67M increase.
- IberiaBank's biggest Q2 2016 reduction was Bristol-Myers Squibb, cutting an estimated $2.88M.
- IberiaBank fully exited Kohl's in Q2 2016, selling an estimated $2.17M.
- IberiaBank's ten largest holdings make up 23% of its $227M portfolio in Q2 2016.
- IberiaBank opened 10 new positions and closed 18 in Q2 2016.
- IberiaBank's portfolio value rose 7.1% quarter-over-quarter to $227M.
Based on IberiaBank's 13F filing for Q2 2016, filed 15 Aug 2016.